Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	Affected	At risk
Total, all-cause mortality	DB Period: Difelikefalin	0	129
Total, all-cause mortality	DB Period: Placebo	0	130
Total, all-cause mortality	OLE Period: Difelikefalin/Difelikefalin	0	103
Total, all-cause mortality	OLE Period: Placebo/Difelikefalin	0	113
Total, other adverse events	DB Period: Difelikefalin	85	129
Total, other adverse events	DB Period: Placebo	66	130
Total, other adverse events	OLE Period: Difelikefalin/Difelikefalin	65	103
Total, other adverse events	OLE Period: Placebo/Difelikefalin	69	113
Total, serious adverse events	DB Period: Difelikefalin	18	129
Total, serious adverse events	DB Period: Placebo	12	130
Total, serious adverse events	OLE Period: Difelikefalin/Difelikefalin	19	103
Total, serious adverse events	OLE Period: Placebo/Difelikefalin	12	113

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNone stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05885737/event-totals